Current Group Members


Dr Tameryn Stringer, fixed-term lecturer (2021-present)

Tameryn conducted her Ph.D. on the development of metal-based antimalarials at the University of Cape Town, South Africa and graduated in 2014. She worked as a Postdoctoral Research Fellow at the University of Cape Town until 2017 and also conducted postdoctoral research in Bioorganometallic chemistry at Lund University between 2017 and 2018. In 2020, she moved to the UK to take up the position of Teaching and Research Fellow at the University of Leeds until she moved to the University of East Anglia in August of 2021. Tameryn is a synthetic chemist with expertise in the design, synthesis and characterisation of organic and metal-based compounds as potential biological agents. Tameryn’s research interest involves working towards the development of metallodrugs to combat cancer as well as infectious diseases, including malaria. She is also interested in understanding the mechanism of action and identifying the biological targets of these compounds by means of developing chemical probes and using chemical biology approaches to do so.

Twitter: @tameryn19 | Instagram: @drtams19 |

Dr Benjamin Hofmann, Senior Research Associate (2021-present)

Dr Yi-Hsuan Lee, Research Technician (2022-present)

PhD Students

Oliver King (2020-present)

Oliver started his academic career at the University of Nottingham graduating with a MSci (hons) (2013-2017). During this time, he also carried out a research project in the group of Professor Slyvestre Bonnet at Leiden University, where he worked on the synthesis of tetradentate gold(III) complexes for the treatment of cancer. After graduation, Oliver worked as an associate chemist/engineer within the T&I team at the leading polymer company Celanese (2018-2020). In this role, he assisted with the development of new high value thin film products and supporting manufacturing. In October 2020, Oliver joined the Lord group as a Ph.D. researcher working on vanadium NHCs complexes and assessing their potential as anticancer agents. Currently his work is focused on the synthesis of lipophilic bidentate-NHCs for biological testing.

Enas Aljohani (2021-present)

Katie Littler (2022-present)

Postgraduate Students

Karina Chan (2023-present) – MSc in molecular medicine (BIO)

Undergraduate Students